Merz Pharmaceuticals, LLC et al v. MSN Pharmaceuticals Inc.
| Merz Pharmaceuticals, LLC and Merz North America, Inc. |
| MSN Pharmaceuticals Inc. |
| 1:2021cv01032 |
| July 15, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 29, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 9
SO ORDERED Granting #8 Stipulation Regarding Venue and Personal Jurisdiction. Signed by Judge Richard G. Andrews on 7/29/2021. (nms)
|
| Filing 8 STIPULATION Regarding Venue and Personal Jurisdiction by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) |
| Filing 7 STIPULATION TO EXTEND TIME Defendant's Deadline to Answer, Move or Otherwise Respond to the Complaint to October 25, 2021 - filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) |
|
SO ORDERED, re #7 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: MSN Pharmaceuticals Inc. answer due 10/25/2021). Signed by Judge Richard G. Andrews on 7/29/2021. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued as to MSN Pharmaceuticals Inc.(please complete the top portion of the form and print out for use/service). (smg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz Pharmaceuticals GmbH & Co. KGaA, Corporate Parent Merz, Incorporated for Merz North America, Inc., Merz Pharmaceuticals, LLC filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (smg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552 ; 7,816,396. (smg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 9, 2021. Date of Expiration of Patent: August 20, 2023.Thirty Month Stay Deadline: 12/9/2023. (smg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3658208.) - filed by Merz Pharmaceuticals, LLC, Merz North America, Inc. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(smg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
